Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : C. Jezequel

A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment

S. Lalanne , C. Tron , M. C. Verdier , C. Jezequel , M. Mercerolle et al.
Fundamental & Clinical Pharmacology, 2021, 35, pp.182-183
Journal articles hal-03329976v1

High intrapatient variability of tacrolimus exposure is associated with poorer outcomes after liver transplantation

Camille Tron , M. Rayar , C. Jezequel , A. Petitcollin , P. Houssel-Debry et al.
15th International congress of Therapeutic Drug Monitoring and Clinical Toxicology, Sep 2017, Kyoto, Japan
Conference papers hal-02463139v1

Managing Drug-Drug Interaction between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil

F. Lemaitre , Z. Ben Ali , C. Tron , C. Jezequel , C. Boglione-Kerrien et al.
Therapeutic Drug Monitoring, 2017, 39 (4), pp.305-307. ⟨10.1097/FTD.0000000000000397⟩
Journal articles hal-01614699v1

P0709 : Survival of patients infected by chronic hepatitis c and f0f1 fibrosis at baseline after a 15 years follow-up

C. Jezequel , Edouard Bardou-Jacquet , Y. Desille , I. Renard , F. Lainé et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S589, 2015, ⟨10.1016/S0168-8278(15)30912-0⟩
Conference poster hal-01162776v1
Image document

The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation A retrospective cohort study

A. Huguet , M. Latournerie , P.H. Debry , C. Jezequel , L. Legros et al.
Nutrition, 2018, 51-52, pp.73-79. ⟨10.1016/j.nut.2018.01.008⟩
Journal articles hal-01777713v1

Managing drug-drug interaction between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir and Mycophenolate mofetil

C. Tron , F. Lemaître , Z. Ben Ali , C. Leven , C. Jezequel et al.
Fundamental & Clinical Pharmacology, 2016, 30, pp.85--85
Journal articles hal-01310757v1

Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: can we target trough concentrations below 7 ng/ml during the first month?

F. Lemaitre , C. Tron , C. Jezequel , S. Lalanne , M. C. Verdier et al.
Fundamental & Clinical Pharmacology, 2021, 35, pp.82-82
Journal articles hal-03329940v1

Deciphering pharmacogenetic-whole blood/intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

C. Tron , J. B. Woillard , P. Houssel-Debry , V. David , M. Rayar et al.
Fundamental & Clinical Pharmacology, 2021, 35, pp.168-168
Journal articles hal-03329966v1

O095 : High transferrin saturation during maintenance venesection therapy in HFE hemochromatosis is associated with increased morbidity regardless of serum ferritin levels

Edouard Bardou-Jacquet , C. Jezequel , J. Morcet , F. Lainé , D. Guyader et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S242, ⟨10.1016/S0168-8278(15)30114-8⟩
Conference papers hal-01162708v1

Baseline serum ferritin is an independent predictive factor of mortality in patients with chronic hepatitis C after long term follow-up

C. Jezequel , Z. B. Ali , C. Pronier , A. Rabot , I. Renard et al.
Journal of Hepatology, 2017, 66 (1), pp.S275--S275. ⟨10.1016/S0168-8278(17)30864-4⟩
Journal articles hal-01559891v1

Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

P. Houssel-Debry , C. Duvoux , A. Coilly , C. Fougerou-Leurent , C. Jezequel et al.
Journal of Hepatology, 2016, 64 (2), pp.S144--S145. ⟨10.1016/S0168-8278(16)01652-4⟩
Journal articles hal-01533345v1